A Study to Determine Why Some Women Age Fifty and Over Choose Not to Have Frequent Papanicolaou Tests by Hicks-Burchwell, Dorothy
Grand Valley State University
ScholarWorks@GVSU
Masters Theses Graduate Research and Creative Practice
6-2-2000
A Study to Determine Why Some Women Age
Fifty and Over Choose Not to Have Frequent
Papanicolaou Tests
Dorothy Hicks-Burchwell
Grand Valley State University
Follow this and additional works at: http://scholarworks.gvsu.edu/theses
Part of the Nursing Commons
This Thesis is brought to you for free and open access by the Graduate Research and Creative Practice at ScholarWorks@GVSU. It has been accepted
for inclusion in Masters Theses by an authorized administrator of ScholarWorks@GVSU. For more information, please contact
scholarworks@gvsu.edu.
Recommended Citation
Hicks-Burchwell, Dorothy, "A Study to Determine Why Some Women Age Fifty and Over Choose Not to Have Frequent
Papanicolaou Tests" (2000). Masters Theses. 492.
http://scholarworks.gvsu.edu/theses/492
A STUDY TO DETERMINE WHY SOME WOMEN AGE FIFTY AND OVER
CHOOSE NOT TO HAVE 
FREQUENT PAPANICOLAOU TESTS
By
Dorothy Hicks-Burchwell 
A THESIS
Submitted to 
Grand Valley State University 
in partial fulfillment o f the requirements for the 
degree of
MASTER OF SCIENCE IN NURSING
Kirkhof School of Nursing
June 2, 2000
Thesis Committee Members; 
Patricia Underwood, Ph D., R.N. 
Phyllis Gendler, Ph.D., R.N. 
Kalyana Misra, M.D., M.S.W.
ABSTRACT
A STUDY TO DETERMINE WHY SOME WOMEN AGE FIFTY AND OVER 
CHOOSE NOT TO HAVE FREQUENT PAPANICOLAOU TESTS
By
Dorothy Hicks-Burchwell 
This discriptive study used the Health Belief Model to examine the benefits, 
barriers, and action cues to obtaining Papanicolaou tests perceived by women age 50 and 
older. A convenience sample of 48 women were interviewed. Comparisons were made 
between those who obtained Papanicolaou tests at least every three years (n = 24) and 
those who did not (n = 24)..
One cue to action and four perceived benefits were found to be important 
influences. Women who had received Papanicolaou tests less frequently than every three 
years agreed that certain barriers had influenced their decisions more than women who 
had received Papanicolaou tests at least every three years. In addition, women who had 
obtained Papanicolaou tests less frequently perceived less influence from certain benefits. 
Women age 65 and older more firequently identified certain barriers as having influenced 
their decisions than women under 65.
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CHAPTER 1 
INTRODUCTION
There are many women over age 50 o f all races and socioeconomic status who do 
not have frequent Papanicolaou tests performed. There has been limited research 
regarding older women having frequent Papanicolaou tests. In fact, many women age 50 
and older have not had a Papanicolaou test since their last child was bom.
Significance of the Problem
Cervical cancer remains a problem in the United States. According to Herrero 
(1996), “cervical cancer is the second most common cancer among women worldwide, 
with an estimated 471,000 new cases diagnosed and 213,000 deaths occurring in 
1990”(p. 1). In addition, Herrero states (1996), “cervical cancer is the seventh most 
common cancer among women in the United States” (p. 2). Cervical cancer, as reported 
by the National Institutes of Health Consensus Development Panel (NIHCDP) “is one of 
the most common cancers in women and accounts for 15,000 new cases (6% o f all 
cancers) and 4,900 deaths in the United States each year” (1996, p. vii). The Cervical 
Cancer Advisory Committee (1988) states that in the United States invasive cervical 
cancer occurs more often in women 65-years-old and older. Forty to fifty percent of all 
deaths due to invasive cervical cancers occur in women in this age group.
According to Eyster, Spivak, and Deguire (1995), cervical cancer was the third 
leading cancer in women in Michigan ages 25 to 34 in 1994. Cervical cancer was the
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fourth leading cancer in white women between the ages o f 25 and 44, and in black 
women between the ages of 15 and 44. Although the incidence o f  cervical cancer is less 
in women 45 years and older, the death rate is higher. There were 143 deaths to Michigan 
women caused by cervical cancer in 1994. Survival rates for cervical cancer are 68.9%. If 
the cancer is localized, the survival rate is 91.3%.
Most cervical cancers grow slowly. Precancerous cells and cancer can be 
identified via Papanicolaou tests. NIHCDP (1996), states “the majority of squamous cell 
cancers of the cervix progress through a series of well-defined preinvasive lesions and 
that, during this usually lengthy process, the disease can be easily detected by Pap smear 
screening” (p. vii).
The Papanicolaou test has a false negative rate o f 10% to 30% according to 
Merrill, Gusberg, Deppe, and Stafl (1982). Brown (1996) states.
Cervical cancer might be described as an ideal disease for which to implement 
mass population-based screening. A prolonged asymptomatic phase permits early 
detection o f preinvasive disease that is potentially 100% curable, making invasive 
cervical cancer theoretically a completely preventable disease. The screening test 
(Pap smear) is simple and risk free and has acceptable levels of sensitivity and 
specificity. Papanicolaou tests less frequent than annually increase a woman’s risk 
o f cervical cancer due to the false negative rate. In the United States women are 
very mobile and many do not return for follow-up Papanicolaou tests as they are 
advised (p. 7).
According to NIHCDP, (1996), “During the last 50 years in the United States, the 
utilization o f screening programs based on the Papanicolaou (Pap) smear and pelvic
examination has led to a steep decline in incidence o f and deaths from cervical cancer”
(p. vii). If  we decrease the frequency of Papanicolaou testing, we may cause a decrease in 
diagnosis o f precancerous cells. This could cause the cancer to be diagnosed at a later 
stage, which would involve more invasive treatment. Advanced cervical cancer could 
cause death.
Morrison (1990), states “although most o f the cases of cervical cancer occur 
among younger women, approximately half o f all the deaths (56%) occur among women 
65 years and older” (p. 32). Older women are more likely not to have frequent 
Papanicolaou tests and are diagnosed later with cervical cancer. According to Herrero 
(1996, p. 3), cervical cancer “cases are diagnosed at more advanced stages among older 
women than among younger women and among black women than among white 
women.”
Older persons are not valued and respected in the United States. Bernhard and 
Sheppard (1992), state that older women, in particular, are not respected and valued in 
the United Sates and some other societies. Edelman and Mandle (1994), state “American 
culture still values women in part for their youth, beauty and childbearing ability” (p. 
629). It may be difficult for society to recognize what is special about middle-aged 
women. This could affect medical care. Clancy and Massion (1992) foimd that after the 
childbearing years were completed, internists and general practitioners were less likely 
than gynecologists to offer Papanicolaou tests to women. It was also found that many 
women who had recently had a medical visit did not receive a Papanicolaou test although 
it was indicated. This was even more likely if the woman was poor. According to White 
(1995), prejudices exist concerning the provision o f medical care for the older person.
Stereotypes reflect an emphasis placed on calendar age rather than on physical, mental 
and social abilities. Women, in particular, suffer the effects o f ‘ageism’ in relation to 
preventive medicine.
Women, according to Legato (1995), “make two-thirds o f health care decisions, 
undergo 63% o f adult surgery, fill 60% to 80% of U.S. hospital beds and make up 52% of 
the population” (p. 38). Despite these facts, there have been fewer studies o f women’s 
health care needs and less funding for research in this area than for their male 
counterparts. To reverse this deficit, the National Institutes o f Health will now only fund 
research projects that include both males and females. Women’s health has become more 
of a priority.
Women’s health after age 50 should be a priority for nursing research as well, 
because it represents a major current future health care need for a growing population 
segment. Nursing has an opportunity to contribute to the resolution o f the problem of 
older women not having frequent screening for cervical cancer. By increasing the 
utilization o f frequent Papanicolaou tests for women age 50 and older, cancers could be 
detected earlier. Early detection of cervical cancer would decrease health care costs by 
preventing extensive surgeries and treatment. Treatment would be more effective, less 
expensive, and less traumatic for the patient.
What affects an older woman’s decisions regarding frequent Papanicolaou tests 
has been addressed in previous studies (Burnett, Steakley, & Tefft, 1995; Hoeman, Ku, & 
Ohl, 1996; Lacey, Phillips, Ansell, Whitman, Ebie, & Chen, 1989; White, 1995).
Identified barriers to women age 50 and older having frequent Papanicolaou tests 
included fear, embarrassment, socioeconomic barriers, lack of education and/or
knowledge, and lack o f physician recommendation.
It is important to identify what women age 50 and older perceive as barriers to 
obtaining Papanicolaou tests. When barriers are identified, we may be able to remove 
them by incorporating handicap free modifications, transportation, or other changes to 
assist women to overcome them. It is important to identify what women age 50 and older 
perceive as benefits to obtaining Papanicolaou tests. Perceived benefits could then be 
incorporated into programs developed to promote screening. Cues to action that prompt 
women age 50 and older to have Papanicolaou tests, including recommendation by health 
care provider and influence of significant others, need to be identified. Health care 
providers could then incorporate recommendation o f frequent Papanicolaou tests during 
all clinic visits. Information regarding the importance o f urging your family members and 
friends to have frequent Papanicolaou tests could be encouraged in teaching materials and 
in the media.
This study examined perceived benefits of and barriers to having Papanicolaou 
tests specifically including: (a) fear, (b) cost, (c) embarrassment, (d) lack of education 
regarding the importance of frequent Papanicolaou tests to detect cervical cancer, (e) lack 
o f transportation, and (f) inability to access care due to disability were examined. Cues to 
action including health care provider recommendation and influence o f significant others 
were also examined.
Purpose of the Studv
The purpose o f this study was to describe the reasons women age 50 and older 
gave for obtaining or not obtaining frequent Papanicolaou tests and to examine their 
perceptions o f barriers, cues to action, and benefits o f having the test. These variables
were examined for differences between women who do and do not obtain frequent 
Papanicolaou tests.
CHAPTER 2
CONCEPTUAL FRAMEWORK AND LITERATURE REVIEW 
Conceptual Framework
The Health Belief Model was the organizing framework o f this study. Over the 
past 40 years, the Health Belief Model has been successfully used and tested in 
explaining preventive health behavior, including utilization o f health screening programs. 
According to Maiman and Becker (1974), the Health Belief Model is a 
psychosociological theory that was developed in the 1950s due to certain needs for 
research in public health. The Health Belief Model was used to study health behavior and 
to predict use o f health screening programs.
Maiman and Becker ( 1974) describe the Health Belief Model as having two 
components. One is a person's perception o f vulnerability to a condition and its 
seriousness. The other is perception of value to the individual taking part in a health 
action. This benefit is "weighed against his perceptions of psychological and other 
‘barriers’ or costs’ o f the proposed action (including the ‘work’ involved in taking the 
action)" (pp. 348-349). A cue to action then acts as a stimulus to prompt the individual to 
ultimately take part in the health action.
According to Rosenstock, (1960), "the motive that determines whether health- 
related actions will be taken depends upon the degree to which the individual feels 
threatened by a given disease" (p. 297). He must also see some action available “which
he believes would either reduce the likelihood o f occurrence or the seriousness o f the 
problem” (p. 297).
Rosenstock (1960) states that even if a person is adequately motivated to take 
action, "a conflict may occur to influence ultimate behavior if the action he is required to 
take is in itself unpleasant, painful, or upsetting (p.298)." When a person is very 
frightened or anxious, he or she may not be able to think rationally about the health 
action. The anxiety and/or fear may prevent action.
Kirscht (1974), states "the model is useful if  it implies that there are ways to 
activate beliefs already in existence, or if it implies that, as a result o f belief change in the 
‘right’ direction, appropriate behavior becomes more likely" (p. 455). Kirscht explains 
that there is a need for a stimulus for the necessary belief to be called into action. Kirscht 
states.
If  the individual perceives greater threat from an ill health condition, or if 
health motivation is increased, or if the perceived value and/or likelihood 
o f an action to reduce a threat is increased, or i f  the costs of an action that 
is efficacious against a threat are reduced, or if  some combination of these 
changes takes place, then the likelihood o f the action is increased (p. 455). 
According to Becker, Haefiier, Kasl, Kirscht, Maiman, and Rosenstock (1977), 
the Health Belief Model includes the individual's "subjective state of readiness to take the 
action" (p. 29). Readiness is influenced by perceptions o f  susceptibility to the disease and 
perceptions o f severity of the consequences of having the disease. Becker (1977) states 
the Health Belief Model includes perceived benefits o f the health behavior, "an estimate 
of the action's potential benefits in reducing susceptibility and/or severity” (p. 29).
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Benefits are weighed against costs or barriers. Perceived costs or barriers can be 
financial, social, psychological or physical. A stimulus is needed to prompt the action. A 
cue to action, according to Becker et al. (1977, p. 29), "can be either internal (e.g., 
symptoms) or external (e.g., interpersonal interactions, mass media communications"). 
Leventhal, Safer, and Panagis (1983) describe the Health Belief model as including four 
components:
1. The individual's perception of his or her vulnerability to a health threat;
2. The perception o f the severity of the threat;
3. The perception o f  benefits versus the perception of costs from taking the 
recommended action; and
4. Cues to action.
Individuals must perceive health threats that are significant to them. They must 
believe that the benefit o f  having the health screening outweighs the perceived cost to 
them, and they must have a stimulus to prompt them to access the health screening. The 
people's perceptions regarding their vulnerability and the seriousness of the health threat 
are what prompts action and not the actual reality.
Champion (1993) stated that two additional components are important: general 
motivation and confidence. Champion used the HBM to study the practice o f breast self- 
examination (BSE). She found that benefrts and barriers were significant predictors for 
utilization of breast cancer screening services with barriers consistently accounting for 
the most variance in BSE behavior. General health motivation and confidence were found 
to be positively related to BSE.
The salience of the individual components of the HBM has varied across studies. 
Rutledge (1987) studied BSE using the HBM as the theoretical framework. She found 
that the four major HBM components were predictors of whether a woman will perform 
BSE: “(a) her perceived susceptibility to breast cancer and perceived seriousness of the 
consequences o f breast cancer, and (b) her perceptions of the benefits and barriers to 
BSE” (p. 117). Kim, Horan, Gendler, and Patel (1991) used the Health Belief Model to 
develop the Osteoporosis Health Belief Scale. They found that barriers and health 
motivation were the most important constructs in explaining both calcium intake and 
exercise behaviors.
Stein, Fox, Murata, and Morisky (1992) studied the influence o f the HBM 
constructs on prior mammography usage and the intention to obtain mammograms using 
information from a group of 1,057 women who were 35 years old and lived in an urban 
community. They found that “cues to action, operationalized as a physician influence 
variable, were related to prior mammography, while perceived susceptibility was the 
most powerful predictor of future intentions to obtain a mammogram.” (p. 447). In this 
study perceived barriers were found to be less significant than perceived benefits.
Hijeck (1984) developed a tool to predict patient entrance and participation in a 
cardiac rehabilitation program using the Health Belief Model as a conceptual framework. 
Hiject found all aspects of the Health Belief Model to be useful.
The Health Belief Model has been used successfully to study health behaviors for 
over 40 years. O f the four major HBM constructs, perceived benefits and perceived 
barriers have exerted the greatest influence on health promoting behaviors (Becker et al., 
1977; Champion, 1993; Hijeck, 1984; Kim et al., 1991; Kirscht, 1974; Leventhal et al.,
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1983; Rosenstock, 1974; Rutledge, 1987; Stein et al., 1992) with benefits and barriers 
having relatively more or less influence in particular studies.
The HBM has provided the conceptual framework for this study. The focus was 
on examining the perceptions o f women over 50 regarding the benefits of and barriers to, 
obtaining frequent Papanicolaou tests. Women who have and have not had frequent 
Papanicolaou tests were compared with respect to the reasons they gave for their 
decision.
Literature Review
The purpose o f this study was to identify what factors influence women's decision 
making regarding frequent Papanicolaou tests after age 50. The focus of the review was 
on the benefits and barriers that are documented in empirical studies as affecting the 
frequency o f Papanicolaou testing.
Svstem factors. According to Blesch and Prohaska (1991), older women are not 
screened for cervical cancer as regularly as younger women. Under-representation of 
older women in populations screened is a major issue, both by organized screening 
programs and by individual physicians. Blesch and Prohaska found that patients who 
received care from a gynecologist received Papanicolaou tests more often than those who 
received care from a general practitioner or internist. It was postulated that when women 
presented at the doctor’s office for nongynecological problems, treatment of the medical 
condition was the focus rather than screening. This practice might be due to the general 
practitioners and internists not being skilled or comfortable doing Papanicolaou tests.
According to the American College of Physicians Ad Hoc Committee on 
Women’s Health (ACPAHCWH, 1997), women past childbearing age often do not see a
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gynecologist for care. They are more likely to be seen by a general practitioner or 
internist; therefore, it is important that women’s health care transcends reproductive care 
and should address the broad spectrum of health concerns o f adult women throughout 
their life cycle. The Papanicolaou test and pelvic exam should be a part of routine 
women’s health care whether they choose to be cared for by a general practitioner, 
internist, or gynecologist.
The pelvic examination and Papanicolaou test can be very stressful for some 
women. Many older women experience fear or embarrassment. Some women experience 
pain or discomfort during the pelvic examination and Papanicolaou test. Other women do 
not understand why they need a pelvic examination and Papanicolaou test. Blesch and 
Prohaska (1991) stated, “Having had a hysterectomy does not preclude a need for 
gynecologic health care and Pap smear” (p, 145). Older women who have had a 
hysterectomy are less likely to receive subsequent Papanicolaou tests. This includes those 
women who had a hysterectomy due to cancer. Women who had a hysterectomy were 
included in a study done by Mandelblatt and Hammond (1985) to determine if  
Papanicolaou testing was necessary in older women. It was found by Mandelblatt and 
Hammond that “one o f  the abnormal Pap smears occurred in a woman who had a total 
hysterectomy. On biopsy this proved to be an early vaginal squamous cell carcinoma” (p. 
287).
Older women have different health care needs than women of childbearing age. 
Clancy and Massion (1992) examined the difference between what should be done in 
women's health care and what actually is done. They state that a growing proportion of 
older women have both a higher incidence of disease and fewer resources to pay for
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health care. These women are less likely to have had a recent Papanicolaou smear in spite 
o f having had a recent physician visit. A physician visit is often rushed and focused on 
the presenting symptom. Preventive health services can easily become minimized and 
often go unmentioned.
In a study done by Burnett, Steakley, & Tefft (1995), it was found that provider- 
client relationships and respect for clients influenced whether women accessed cancer 
screening services. According to Allen, Gilchrist, Levenson, and Roter (1993), women 
prefer health care providers who take more time and address their concerns. These 
women are more likely to have frequent Papanicolaou tests and other preventive health 
services.
The Writing Group of the 1996 American Academy o f Nursing (AAN) Expert 
Panel on Women’s Health (1997) stated that in the past women's health has "been viewed 
as reproductive health; however, more recently women's health has been redefined as 
encompassing the entire life span, and women's health care has been redefined as 
including health promotion, maintenance, and restoration (p.7)." Inability to pay for 
health care was identified as a barrier.
Frequencv o f screening. Morrison ( 1997) discussed the need for regular 
Papanicolaou smears. According to Morrison (p. 1283), "Cervical carcinoma in situ was 
diagnosed in more than 65,000 women in 1995 (lifetime risk: 2%); invasive cervical 
cancer was diagnosed in 15,800 women (lifetime risk: 0.7%), and 4,800 others died of 
cervical cancer." Older women are four times more likely to have invasive cervical 
cancer occur than the average rate o f occurrence. In addition, Morrison (1997) states, “the 
controversy surrounding the Pap smear in the late 1990s is not whether to do the
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screening, but when to do it” (p. 1283). Cost has become an important issue in regard to 
recommendations for frequency of Papanicolaou test. Morrison (1997) presents 
recommendations for frequency o f Papanicolaou tests from different medical 
organizations. These recommendations are not consistent. Each organization has its own 
guidelines. Morrison states that the United States Preventive Services Task Force 
recommends Papanicolaou tests at least every three years if  a woman is sexually active or 
after eighteen years of age if  sexual history is in question. The American Academy of 
Family Physicians recommend annual Papanicolaou tests for all women over age 18. 
After three consecutive normal Papanicolaou tests, the test may be done at the frequency 
deemed necessary by the physician, but at least every three years. The American College 
of Obstetricians and Gynecologists recommend that Papanicolaou tests be done every 
year for women 18 and older. After three consecutive normal Papanicolaou tests, the 
Papanicolaou test may be done at the physician's discretion, but at least every 3 years. If 
a woman is considered high risk she should be screened annually.
The Cervical Cancer Control Plan for Michigan, which was written by the 
Cervical Cancer Advisory Committee at Michigan Department of Community Health 
(1998), and which is a part o f the Michigan Cancer Control Initiative, states that the 
guidelines for Papanicolaou testing are “inconsistent” and “lack consensus” regarding 
screening intervals for women of all ages, most especially for women over 65 years of 
age. The Cervical Cancer Control Plan for Michigan (1998, p. 4), states “Increased 
frequency of Pap smear screening decreases the false negative rate o f screening; 
therefore, regular annual Pap smear screening should be emphasized.” According to 
Edelman and Mandle (1994), Papanicolaou tests should be done annually. Brown (1996)
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also recommends that Papanicolaou tests be done every year. Because the guidelines for 
screening intervals for all women and screening after age 65 are inconsistent, many 
physicians may not know which guideline to follow.
Confusion regarding the interval for frequency o f Papanicolaou smears may cause 
physicians to give conflicting information to patients. This is significant because 
physician recommendation has been shown to influence women's decisions to have 
Papanicolaou smears according to Suarez, Nichols, Pulley, Brady, and McAlister (1993).
Sutton, Eisner, and Burklow (1994) state many older people don't know about 
cancer screening. Through the use of focus groups, it was determined that fear was the 
greatest barrier to older persons utilizing cancer screening. A communication program 
was developed that acknowledged fear and empowered older persons to take advantage 
of cancer screening programs including utilization o f Papanicolaou test screening. This 
method of communication "appeared effective in lessening fears about cancer and 
enhancing people's receptivity to being tested” (p. 2197).
Benefits, barriers, and cues to action. A study by Suarez, Nickols, Pulley, Brady, 
& McAlister (1993) involved an effort to increase breast and cervical cancer screening by 
the use of role models. Information was given via mass media regarding the importance 
of breast and cervical cancer screening. Role models’ stories were featured in local 
newspapers. Radio and cable television also presented information. “Volunteers were 
trained, using modeling and role playing, how to recommend going for breast and 
cervical cancer screening” (p. 480). Newsletters were also distributed with information 
about cancer screening services. According to Suarez et al.(1993), the impact on health 
department clinics was positive with increased numbers o f persons screened for breast
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and cervical cancer.
The study done by Suarez et al. (1993), was funded by the National Cancer 
Institute to increase utilization o f breast and cervical cancer screening. A sample o f 107 
women in Corpus Christi and 82 women in Galveston was used for this study. The 
sample included Mexican American women and African American women aged 40 to 60. 
Information was elicited on knowledge, attitudes, and practices regarding cancer 
screening.
The design o f the study was quasi-experimental and data were collected through 
focus groups and a mailed survey. It was found that women beyond childbearing age had 
limited access to information about mammography and Papanicolaou tests. A 
communication effort was launched to bring information to this group. Barriers to having 
a Papanicolaou test were found to be (a) feeling that the examinations were unnecessary, 
(b) cost, (c) lack of physician recommendation, (d) fear, and (e) embarrassment (Suarez 
etal. 1993).
Arevian, Noureddine, and Kabakian (1997) conducted a survey of 290 
Lebanese/Armenian women ages 18 and over (36% of the sample was over age 51) to 
determine the impact of educational level and perceived economic status on women's 
knowledge of, attitudes toward, and practice of cervical screening. A descriptive 
correlational design was used. Cost and embarrassment were found to be significant 
factors in this study. Among women who perceived their income to be low or average, 
cost and embarrassment were the most common barriers to obtaining a Papanicolaou test. 
Women who perceived their income to be high were more concerned with discomfort and 
bad test results.
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A study was conducted to identify barriers to breast and cervical cancer in the 
District of Columbia (Burnett et al., 1995). The sample included 339 women ages 40 to 
77 who were medically under served. A cross-sectional correlational design was used and 
data were collected via interviews. The Theory o f Reasoned Action (TRA) was used as 
the conceptual framework for this study. “Demographic and contextual variables as well 
as attitudes and influence o f significant others” (p. 1551 ) were studied. Contextual 
variables were defined as “history of cancer, previous use of cancer screening tests, 
patient-provider associations, cost and accessibility o f services” (p. 1551).
The dependent variable in the study by Burnett et al. (1995, p. 1551) regarding 
Papanicolaou test was “to  have a Pap test within one year of the last Pap test” and the 
independent variable was attitude toward Papanicolaou tests. Two variables were found 
to be significant in this study, the personal attitude and the attitude o f a significant other 
toward having a Papanicolaou test. Burnett et al. found that a large niunber o f low 
income women and women over 50 years of age were not screened for cervical cancer. 
Women age 50 and older were found to be much less likely to have ever had a 
Papanicolaou test. According to Burnett et al. (1995),
Knowledge o f cervical cancer had a negative relationship with intention to have a 
Pap test (p = 0.004). A significant association was observed between patient- 
provider relationships (e.g., whether the nurse or physician cared for the patient, 
treated her well, or showed her respect) and intention to have a mammogram and 
a Pap test (p = 0.03). No significant relationship was observed between intentions 
and demographic variables, personal history o f cancer, and family history of 
breast or cervical cancer (p. 1555).
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Intention to have a Papanicolaou test and the influence o f significant others was 
positively related to attitude toward Papanicolaou tests. Knowledge of cancer and length 
of time it took to get a Papanicolaou test was reported as having negatively affected 
intention to have a Papanicolaou test. Frequently cited barriers such as cost were not 
significant in this study.
The Barriers to Breast and Cervical Cancer Screening Questionnaire (BBCCSQ) 
was developed for the study and contains 237 items specific to use o f screening services 
and factors that may be barriers. One subscale measured the likelihood a woman would 
have a Papanicolaou test. Another measured likelihood that a woman would have a 
mammogram and do breast self-examination. Knowledge o f cancer of the breast and 
cervix was also measured (Burnett et al., 1995).
An exploratory study was conducted by Hoeman, Ku, and Ohl (1996) to 
determine how participation in early screening for cancer is influenced by cultural beliefs 
and understandings for Chinese women in the United States. The Health Belief Model 
was used as a framework. A sample of 23 Chinese women completed a questionnaire to 
gather information about knowledge and beliefs regarding breast self examination and 
Papanicolaou tests. Over one-third of the women studied thought they should wait until 
after they were 40 years old to start preventive health practices. Husbands were found to 
be cues to action and modesty was a barrier for Papanicolaou smears.
A limitation o f the study was the small sample. Findings cannot be generalized to 
other populations. One strength of the study was that a person o f the same culture and life 
situation was used as the investigator, which facilitated communication with the 
participants (Hoeman et al., 1996).
18
White (1995) studied older women’s attitudes about cervical screening and 
cervical cancer. The purpose o f this qualitative study was to find out how perceptions of 
cancer and Papanicolaou tests affect health screening behavior in older women in New 
Zealand. The sample included nine healthy Caucasian women ages 45 to 70 who were 
referred by a physician. These women had a history o f  no Papanicolaou tests or delayed 
Papanicolaou tests. Data were collected by interview. This study found that many older 
women believed they didn't need a Papanicolaou test. Barriers perceived by the women 
studied included cost, fear, embarrassment, and the belief that older people are no longer 
valued. Not going to the health care provider unless they were sick and believing they 
were too old to have Papanicolaou tests were also influencing factors.
There was also a lack o f understanding that Papanicolaou tests could detect 
precancerous conditions which could be cured and prevent cancer. A limitation o f this 
study was that the findings cannot be generalized. Strengths of the study are that it 
“highlights cognitive, emotional, socioeconomic and ego integrity barriers to regular 
cervical screening (White, 1995, p. 659).
Weinrich, Coker, Weinrich, Eleazer, and Greene (1995) conducted a cross- 
sectional survey to identify factors that indicated participation in Papanicolaou testing. 
The study included 238 women aged 50 years and older. A random selection was done 
from Council on Aging congregate meal sites. Personal interviews were used to identify
(a) those persons who had a Papanicolaou test within the past 2 years, (b) those who had 
not had a Papanicolaou test within the past 2 years, and (c) those who had never had a 
Papanicolaou test. The study found that although 57% had a Papanicolaou test within the 
past 2 years; 26% had one longer than 2 two years ago and 17% had never been tested.
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Lower income was found to be a determining factor for never having had a 
Papanicolaou test. This study also found that not participating in a free screening for fecal 
occult blood was a “significant predictor o f never having had a Pap smear and is not 
reported in previous literature” (Weinrich et al., 1995, p. 268). In addition, “not having 
or being able to use a phone was independently associated with never having a Pap smear 
even after controlling for low income” (p. 269).
Mandelblatt et al. (1993) studied participation in breast and cervical cancer 
screening programs by low income black women. Sample selection was done randomly 
using the clinic appointment schedule. Women selected were 69 years old and older. 
Women were offered same day screening. They were interviewed using a questionnaire. 
Confirmation o f information was done whenever possible by medical record review. 
Scales were developed for measurement which “included the domains o f perceived 
benefit, perceived susceptibility, perceived seriousness, attitudes, life satisfaction and 
knowledge” (p. 22).
Study results showed that those women who stated they would have a 
Papanicolaou test and those women with Medicaid insurance were more likely to 
participate. “A high proportion of elderly, socioeconomically disadvantaged black 
women will participate in cancer screening when it is offered in a primary care setting” 
(Mandelblatt et al., 1993, p. 20). The study found “components o f the health belief 
model, such as perceived benefit and susceptibility to breast and cervical cancer, did not 
predict screening participation” (Mandelblatt et al., 1993, p. 27).
Weaknesses o f this study were, according to Mandelblatt et al. (1993), that the 
results are not generalizable to any population except low-income black women in a
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similar urban clinic. Strengths o f the study were that it targeted older socioeconomically 
disadvantaged black women.
Implications for study. The current health care system does not have a clear 
definition of screening interval for Papanicolaou tests for all women. It also does not 
have a clear definition o f screening recommendations for women over age 65 and women 
who have had a hysterectomy (Association of Professors of Medicine, 1997; Blesch & 
Prohaska, 1991; Cervical Cancer Advisory Committee 1998; Clancy and Massion, 1992; 
Mandelblatt & Hammond, 1985; Morrison, 1997; Suarez et al., 1993). This is significant 
because if  health care providers don’t have clear guidelines for Papanicolaou testing, they 
may be inconsistent in what they recommend. Physician recommendation has been found 
to be a significant factor in women having regular Papanicolaou tests (Suarez et al.,
1993).
In the studies reviewed in this research, variables including (a) fear, (b) cost, (c) 
embarrassment, (d) handicap, and (e) lack of education regarding the importance and 
need for frequent Papanicolaou tests were barriers found to influence women’s decisions 
to have frequent Papanicolaou tests. Health care provider recommendation and 
recommendation o f significant others were cues that influenced obtaining Papanicolaou 
tests. Other significant variables were found in individual studies. White (1995), found 
that women believed that older people are no longer valued. Weinrich, Coker, Weinrich, 
Eleazer, and Greene (1995) found that not being able to use a telephone was a significant 
negative factor. Patient/provider relationship was found to be a significant factor in a 
study done by Burnett, Steakley, and Tefft (1995).
The efficacy o f particular Health Belief Model components continues to vary
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across studies. Stein, Fox, Murata, and Moresky (1992) found perceived barriers to be 
less significant than perceived benefits. Mandelblatt, Traxler, Lakin, Kanetsky, and Kao 
(1993) found that the components o f the HBM, such as perceived benefit and perceived 
susceptibility to breast and cervical cancer, did not predict screening participation.
The studies in this research cannot be generalized to populations other than those 
targeted by the particular study due to small sample size and method of selecting 
subjects. Only one o f the studies reviewed (Weinrich et al., 1995), targeted women age 
50 and over (mean age 72). There is a need for additional studies regarding what 
influences women’s decisions to have frequent Papanicolaou tests after age 50. 
Appropriate strategies to address these factors can then be identified and addressed. 
Research Questions
1. What barriers do women age 50 and older perceive as important to 
decisions related to obtaining Papanicolaou tests?
2. What cues to action do women age 50 and older perceive as important to 
decisions related to obtaining Papanicolaou tests?
3. What benefits o f having Papanicolaou tests are perceived by women age 
50 and older?
4. What differences are there in perceived barriers, cues to action and 
benefits between those who do and do not obtain frequent Papanicolaou 
tests?
Definition o f Terms
Perceived Benefits: The beliefs or perceptions a woman has regarding how 
having a Papanicolaou test will positively affect her health. This includes preventing
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cervical cancer, detection o f precancerous cells, detection of early cervical cancer, 
contributing to health maintenance, or preventing the consequences o f cervical cancer 
including physical, mental, economic, and social consequences.
Perceived Barriers: Beliefs or perceptions a person has regarding the negative 
aspects of having a Papanicolaou test or impediments to obtaining a test. These might 
include financial difficulties, no insurance, embarrassment, inconvenience, time away 
from job or other responsibilities, change in body image, possible side effects o f 
treatment, lack of support system, lack of transportation, fear o f being treated differently, 
fear of pain, and fear o f death.
Cues to Action: A stimulus that occurs to prompt an action. A cue to action 
might include the influence o f a significant other, recommendation by the health care 
provider, an article in the newspaper, other media information, knowledge o f someone 
who was found to have dysplasia or cervical cancer, or personal symptoms o f disease 
thought to be related to cervical cancer.
Frequent Papanicolaou Tests: Frequent Papanicolaou tests as defined in this 
thesis are Papanicolaou tests that are done a minimum o f every 3 years.
Infrequent Papanicolaou Tests: Infrequent Papaiticolaou tests as defined in this 
thesis are Papanicolaou tests that are done less frequently than every 4 or more years.
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CHAPTERS
METHODS
Design
This study was conducted using a descriptive design. The dependent variable in 
the study is women’s stated behavior with regard to obtaining Papanicolaou tests. 
Independent variables to be studied are (a) barriers and (b) cues to action perceived as 
important to decisions with regard to obtaining Papanicolaou tests and (c) perceived 
benefits o f obtaining Papanicolaou tests. The variables were assessed by administration 
of a face to face interview done at three different sites including a Health-O-Rama, a 
senior meal site, and a physician’s general practice clinic.
A convenience sample was used in this study. Two women o f the 48 had been 
referred to me by the physician when they presented for a health problem at the clinic 
because they had not had a Papanicolaou test for over 4 years. Women age 50 and older 
were selected from a rural general practice clinic, a Health-O-Rama, and a senior meal 
site fi-om rural areas. Interviewing continued until 24 women who had received 
Papanicolaou tests every 4 or more years and 24 women who had received Papanicolaou 
tests at least every 3 years were interviewed. Information obtained from this sample 
cannot be generalized to any other population. Extraneous variables including education, 
social class, level o f health, functional status, and attitude were not measured in this 
study.
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The advantage of using a descriptive study design was that there was no necessity 
to manipulate variables. Perceived benefits, barriers, and cues to action that affect women 
obtaining regular Papanicolaou tests were studied to provide information as it naturally 
occurred. Subjects were asked to participate in one interview only which involved 
minimal time investment for the subject and may have increased their willingness to 
participate.
Instrument
The instrument used to collect data was developed for this study (see Appendix 
F). Information was taken from three instruments that had been used in previous studies. 
One instrument was developed by Bumett et al. (1995) to measure barriers to breast and 
cervical cancer screening using the Theory of Reasoned Action (TRA) as a conceptual 
framework. The questionnaire by Bumett et al. includes sections on eligibility and 
demographic data, personal health history, and family health history in Section I. Section 
II contains information on how the subject found out about the breast and cervical cancer 
screening services, transportation to the clinic, and reasons why the subject attended the 
clinic. Part II also includes reasons that would influence the subject not to come back for 
breast and cervical cancer screenings. In addition, the questionnaire asks subjects to 
indicate ways to inform people about the availability of breast and cervical cancer 
examination services that would best reach them. Section III o f the questionnaire asks 
what the subject believes about mammograms, breast self-examination and Pap tests and 
how likely she is to have these exams. Interview was done in Bumett et al.'s study.
According to Bumett et al. (1995), “Content validity was established by 
individuals with expertise related to underserved populations who reviewed and critiqued
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the BBCCSQ for both content and congruence with TRA." Cronbach’s alpha was used to 
test reliability coefficients. Reliability coefficients for each dependent variable were 
between .65 and .87 (p. 1554).
Selected content from all three sections o f the tool developed by Bumett et al. 
(1995) having to do with Papanicolaou testing was used for this study. The information 
was used with permission (see Appendix I) and put into the format o f  benefits, barriers, 
and cues to action commonly seen in the Health Belief Model. Benefits, barriers, and 
cues to action that were found to affect women’s decisions not to have frequent 
Papanicolaou tests that were identified in several studies cited previously were 
determining factors in the selection of items from Bumett et al.’s tool.
The second instrument was developed by Champion (1993) to study breast cancer 
screening behaviors. Champion’s instnunent was used with permission from the author 
(see Appendix H). Champion’s instrument measures confidence, health motivation, 
benefits, barriers, susceptibility, and seriousness. Champion’s study used the HBM as the 
theoretical framework. The purpose o f the study, according to Champion (1993), was to 
“refine an instrument to measure the Health Belief Model concepts o f  susceptibility, 
seriousness, benefits, barriers, health motivation, and confidence, using the context of 
breast cancer and breast self-examination” (p. 139). Various questions from Champion’s 
tool were used in the instrument to collect data in this study. Wording was changed so 
that the questions asked what influenced women’s decisions regarding obtaining 
Papanicolaou testing rather than mammogram testing. The questions related to barriers 
and benefits in Champion’s tool were used in this study’s instrument also. Champion 
used a response option o f (a) strongly disagree, (b) disagree, (c) neutral, (d) agree, and (e)
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strongly agree. She used a 5-point scale with strongly disagree being 1 and strongly agree 
being 5. The same response options were used in this study to determine what influences 
women to obtain Papanicolaou tests 5.
The third instrument was developed by Kim, Horan and Gendler (1991). This 
instrument was developed based on Champion’s (1993) instrument and utilized an 
interview format. The format for interview from Kim et al’s study was used with 
permission to develop an interview format for this study (see Appendix G). A 5-point 
scale was used in Kim et al’s study (1991) with a response option o f (a) strongly 
disagree, (b) disagree, (c) neutral, (d) agree, and (e) strongly agree. They used a 5-point 
scale with strongly disagree being 1 and strongly agree being 5. Kim et al. used a written 
explanation, which was printed on each interview form to explain what their study was 
about. It also contained information regarding the interview process including the fact 
that the interviewer was going to ask them some questions about osteoporosis. It stated 
there were no right or wrong answers and that different experiences affect how people 
feel. It instructed the subject to tell the interviewer if  they (a) strongly disagree, (b) 
disagree, are (c) neutral, (d) agree, or (e) strongly agree. In the directions it was stated 
that the subject should answer the questions according to her beliefs and not how she 
thought the interviewer wanted her to answer or how she thought she should answer. The 
information from Kim et al’s tool explaining what the interview was about and 
instructing the participant how to follow the directions was used in this study. This 
information was read to each participant before asking the questions.
The interview tool used in this research included three main sections. The first 
section included 14 questions that identified perceived barriers (see Appendix F,
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questions 1-14), the second section included four questions that identified perceived cues 
to action (see Appendix F, questions 15-18), and the third section contained four 
questions that identified perceived benefits o f  having Papanicolaou tests (see Appendix F, 
questions 19-22). Question 23 was an open-ended question asking for other influences 
not included in the interview tool. In addition, the instrument requested information 
regarding frequency o f past Papanicolaou tests, the age o f the subject, and race. The 
interview tool included specific written directions including response options. Directions 
were read to each study participant prior to questions being asked. Response options 
included five choices which were written on a card and given to the subjects to choose 
from. Response choices included a 5-point scale (a) strongly disagree, (b) disagree, (c) 
neutral, (d) agree, and (e) strongly agree with strongly disagree scored as 1 and strongly 
agree scored as 5.
Five women age 50 and over read the instrument developed for this research to 
assess if it was easy to understand. The instrument was also reviewed by two experts for 
content validity. The instrument was then pilot tested on five women age 50 and over to 
ascertain if any changes should be made. Because the instrument used in this research has 
not been tested for reliability, Cronbach’s alpha was evaluated for each subscale. 
Reliability coefficients for barriers were found to be alpha = .76. Cues to action had a 
reliability coefficient o f alpha = .35, and the reliability coefficient for benefits were alpha 
= .78.
Procedures
Subjects were identified when they presented for services at a rural general 
practice clinic, a Health-O-Rama in a rural area, and at a senior meal site. All women
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over age 50 were asked if  they would participate in a study to determine what influences 
women’s decisions to obtain Papanicolaou tests. A letter o f introduction was given to all 
subjects who agreed to participate in the study explaining the study and introducing the 
researcher as the interviewer (see Appendix D). The researcher’s phone numbers at home 
and at work were included in the letter in the event there were any questions after the 
interview. The phone number for the Chairperson of the Human Research Review 
Committee at Grand Valley State University was also given to subjects in the letter of 
introduction so they could call him with any questions. An informed consent was signed 
by all subjects prior to the interview (see Appendix E).
The consent form included information about why the subject was selected for the 
study, a statement that information would be confidential, and a statement that a 
summary of results would be available to the subject upon request. The consent form also 
stated that subjects were acknowledging that an opportunity was given for them to ask 
questions, that participation in the study was voluntary, that they could withdraw at any 
time, and that the phone number for the Human Research Review Committee at Grand 
Valley State University had been given to them. A statement o f authorization for the 
investigator to release information in the study to scientific literature was also included.
Data was collected regarding benefits, cues to action, and barriers affecting 
women obtaining regular Papanicolaou tests. There was no intervention in this study. 
Subjects were requested to answer questions in a face-to-face interview. One person 
performed all interviews. Prior to the question and answer portion o f the interview, a 
prepared statement was read to each subject explaining the interview’s purpose. Subjects 
were informed that the interview questions would pertain to factors that may affect their
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decisions to have Papanicolaou tests. They were read directions regarding how to answer 
questions including response choices. A card was given to each subject which listed the 
five possible choices as responses to each question. Instructions for utilizing the five 
possible responses listed on the card as answers to the questions were read from the 
interview form. The subjects were instructed to answer the way they believed and not the 
way they thought they should answer or the way they thought the interviewer might want 
them to answer (see Appendix F). The response to each question was recorded on the 
interview form by the interviewer. Study participants were informed that all information 
given by them during the interview was confidential. They were asked to give 
demographic information regarding age and race. They were also asked to give 
information regarding frequency o f past Papanicolaou tests.
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CHAPTER 4 
DATA ANALYSIS
Techniques
Nominal and ordinal data were collected by face-to-face interviews. Subjects 
indicated their agreement on a 5-point scale (strongly agree = 5) with the importance o f 
factors influencing their decisions regarding Papanicolaou tests. Percentages were 
calculated for the responses to each question in the interview. Data was collapsed 
combining agree and strongly agree and also combining disagree and strongly disagree 
due to numbers being so small. Differences in perceived barriers to having Papanicolaou 
tests were analyzed using the Mann Whitney U test. This was done to determine what had 
influenced women who had less frequent Papanicolaou tests compared to those women 
who had more frequent Papanicolaou tests. This enabled the researcher to identify what 
barriers, cues to action, and benefits affected one group more frequently than another. 
Characteristics o f Subjects
Forty-eight women age 50 and older were included in the study. This included 24 
women who had had Papanicolaou tests at least every 3 years and 24 women who had 
had Papanicolaou tests less frequently. A convenience sample was obtained from three 
sites; a rural Health-O-Rama, a rural senior meal site, and a rural general practice clinic. 
Subjects were interviewed in person until an adequate number o f women had 
participated. Ages ranged from 50 to 85 years o f age with 48% (n = 23) between the ages
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of 50 and 64 and 52% (n = 25) between 65 and 85 years o f age. Nearly all of the women 
included in this study were Caucasian (93.8%). A small percentage of women were 
American Indian (4.2 %) and Asian (2.1%).
All women in the study had obtained Papanicolaou tests at some time in their 
lives. Fifteen women (31%) had obtained Papanicolaou tests every year and fourteen 
women (29%) in the study had obtained Papanicolaou tests every 4 or more years. Ten
Frequency of Papanicolaou Tests of Study Participants
Less frequently then every 10 years  (10 women) % |
Every four or more years (14 women)) J
Every two to three years (9 women)
Every Year (15 women)
0% 5% 10% 15% 20% 25% 30% 35%
Figure 1. Bar Graph Depicting Frequency of Papanicolaou Tests of Study Participants
women (21%) had obtained Papanicolaou tests less frequently than every 10 years and 
nine women (19%) had obtained Papanicolaou tests every 2 to 3 years (see Figure 1).
In this sample, the frequency o f obtaining Papanicolaou tests differed according to age
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with women under age 65 (27%) obtaining tests more frequently than women age 65 and 
older (23%) (see Table 1).
Frequent Papanicolaou tests as defined in this thesis are Papanicolaou tests that 
are done every 1 to 3 years. Infrequent Papanicolaou tests as defined in this thesis are 
Papanicolaou tests that are done every 4 or more years (see Figure 1).
Table 1. Comparison o f Frequency of Obtaining Papanicolaou Tests According to Age
Age
Frequent
(n)%
Infrequent
(n)%
Totals
(n)%
Under 65
(n = 23) (13)27.08 (10) 20.83 (23) 47.91
65 and over
(n = 25) (11)22.91 (14) 29.16 (25) 52.07
Research Questions
This study specifically sought to answer the following questions;
1. What barriers do women age 50 and older perceive as important to
decisions related to obtaining Papanicolaou tests ?
2. What cues to action do women age 50 and older perceive as important to
decisions related to obtaining Papanicolaou tests?
3. What benefits of having Papanicolaou tests are perceived by women age
50 and older?
4. What differences are there in perceived barriers, cues to action and
benefits between those who do and do not obtain frequent versus 
infrequent Papanicolaou tests?
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Method o f Analysis
In this study, analysis of what barriers women age 50 and older perceived as 
important to decisions related to obtaining Papanicolaou tests was accomplished by 
comparing the percent of agreement or mean ranks among questions 1-14 on the 
interview form (see Appendix F). Those questions involved barriers that could prevent 
women from obtaining Papanicolaou tests. Mean agreement scores were used to rank the 
importance o f  specific barriers in influencing women age 50 and older regarding 
obtaining Papanicolaou tests.
Questions number 15-18 related to perceived cues to action and questions 19-22 
related to perceived benefits included in the interview were analyzed in the same manner. 
The questions regarding perceived cues to action involved a stimulus that could prompt 
women to obtain Papanicolaou tests. The questions regarding perceived benefits involved 
benefits to obtaining Papanicolaou tests. Mean responses were used to rank the 
importance o f barriers, cues to action, and benefits in influencing women age 50 and 
older regarding obtaining Papanicolaou tests. Data was collapsed by using the total of 
responses to agree and strongly agree and the total o f disagree and strongly disagree due 
to the small numbers involved. Differences in perceived barriers, cues to action, and 
benefits between those who do and do not obtain frequent Papanicolaou tests were then 
analyzed by using the Mann Whimey U test on an item to item basis.
Research Question Number One
Research question number one asked what barriers women age 50 and older 
perceive as important in influencing their decisions to obtaining Papanicolaou tests. The 
vast majority o f  the sample did not consider any of the barriers to be important to their
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decisions about obtaining Papanicolaou tests. Mean responses were used to rank the 
importance o f barriers to having Papanicolaou tests. Embarrassment was the response 
with the highest-ranking mean (M = 2.48, SD = 1.29). Lack o f insurance coverage had 
the second highest-ranking mean (M = 2.42, SD = 1.35). The percent of subjects who did 
agree that particular barriers were important to their decision making were examined. 
Twenty-seven percent were in agreement that not having insurance was a barrier and 
another 27% were in agreement that embarrassment was a barrier. Cost o f Papanicolaou 
tests was reported as a barrier by 21%, and 21% agreed that having a Papanicolaou test 
would make them worry. When asked if pain was a barrier to obtaining Papanicolaou 
tests, nearly 17% were in agreement. Nearly 15% o f the subjects agreed that testing for 
cervical cancer was not important and that this had influenced their decisions regarding 
obtaining Papanicolaou tests. Subjects were asked if not knowing about Papanicolaou 
tests had influenced their decisions and over 12% were in agreement (see Table 2). 
Research Question Number Two
Research question number two asked what cues to action women 50 and older 
perceived as important to decisions to obtain Papanicolaou tests. Health care provider 
recommendation was found to have the strongest agreement with 60% of study 
participants agreeing that it had prompted action. When asked if the media had influenced 
decisions regarding Papanicolaou tests, 33% agreed. Twenty-seven percent were in 
agreement that when a friend had cancer and wanted them to take better care o f their 
health, it had influenced their decisions to obtain Papanicolaou tests. Almost 21% were in 
agreement that when a family member reminded them to have Papanicolaou tests, it 
influenced their decisions (see Table 3).
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Table 2. Number and Percent of Agreement on Barriers to Papanicolaou Tests
Interview Question 
(n = 48)
Agreement 
(n) %
Lack o f insurance coverage (13) 27.1%
Having a Pap test would 
be embarrassing (13) 27.1%
Cost too much (10) 20.8%
Having a Pap test would 
make me worry 
about cancer (10) 20.8%
Inconvenient time (8) 16.7%
Having a Pap test 
would be painful (8) 16.7%
Didn’t think testing for 
cervical cancer 
was important (7) 14.6%
Didn’t know about 
about Pap tests (6) 12.5%
Bad treatment by health 
care staff in the past (4) 8.3%
Inconvenient location (4) 8.3%
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Table 3. Number and Percent of Agreement on Cues to Action to Papanicolaou Tests
Interview Question 
(n = 48)
Agreement 
(n) %
Clinic/physician/nurse 
recommended you have 
a Pap test (29) 60.4%
Television program, newspaper 
article, radio advertisement, or 
other media information about 
the need for Pap test (16) 33.3%
Someone you know, 
recently diagnosed with 
cancer, wanted you to take 
better care of your health (13) 27.1%
A family member 
reminded you (10) 20.8%
Mean responses were used to rank the importance of cues to action to having 
frequent Papanicolaou tests. In this study, mean ranking for cues to action showed (a) 
health care provider recommendation to have the most agreement (M = 3.27, ^  = 1.30),
(b) media information regarding need for Papanicolaou tests was second highest (M = 
2.67, SD = 1.21), and (c) someone you know, recently diagnosed with cancer, wanted 
you to take better care of your health (M = 2.54, SD = 1.13) was ranked third.
Research Question Number Three
Research question number three asked what benefits o f having Papanicolaou tests 
do women age 50 and older perceive to have influenced their decisions to obtain 
Papanicolaou tests. When asked if having Papanicolaou tests would find precancerous 
cells, over 85% o f women in the study were in agreement that this was an important
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benefit to them (see Table 4). When subjects were asked if  having Papanicolaou tests 
would help find cancer earlier, slightly over 81% were in agreement. Seventy-nine 
percent o f subjects were in agreement that having Papanicolaou tests would decrease 
chances o f death from cervical cancer if cervical cancer occurred, and 79% were in 
agreement that having Papanicolaou tests would decrease chances of radical surgery if 
cervical cancer occurred.
Mean responses were used to rank the agreement that particular factors were 
benefits to having frequent Papanicolaou tests. According to this ranking, the benefit of 
finding cervical cancer early had the most agreement (M = 3.98, ^  = .89). Belief that a 
Papanicolaou test will help find abnormal cells before they actually become cervical 
cancer was ranked second (M = 3.83, SD = 1.08) and having a Papanicolaou test will 
decrease the chances of dying from cervical cancer (M = 3.83, SD = 1.10) ranked next. 
Having a Papanicolaou test will decrease the chances o f  requiring radical surgery if  
cervical cancer occurs had the next highest ranking mean benefit (M = 3.71, SD = 1.07). 
Research Question Number Four
Differences in responses between those who have frequent Papanicolaou tests and 
those who have infrequent Papanicolaou tests regarding individual barriers, cues to 
action, and benefits were tested using the Mann Whimey U test. Frequent Papanicolaou 
tests were defined in this study as Papanicolaou tests obtained at least every 3 years. 
Infrequent Papanicolaou tests were defined in this study as Papanicolaou tests obtained 
every 4 or more years. Since the number of subjects in the largest group exceeded 20, the 
z statistic was used to determine significance. There were no significant differences with 
regard to cues to action.
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Table 4. Number and Percent of Agreement on Benefits to Papanicolaou Tests
Interview Question 
(n = 48)
Agreement 
(n) %
Having a Pap test will 
help find abnormal cells 
before they actually 
become cervical cancer (41) 85.4%
Having a Pap test will help 
find cervical cancer early (39) 81.3%
Having a Pap test will 
decrease the chances o f 
dying from cervical cancer (38) 79.2%
Having a Pap test will 
decrease the chances of 
requiring radical surgery 
if cervical cancer occurs (38) 79.2%
Barriers. Barriers that were found to have significant differences between those 
who do and do not have frequent Papanicolaou tests included (a) not knowing where to 
go for Papanicolaou tests, (b) inconvenient time, and (c) not believing Papanicolaou tests 
were important. The barrier “not knowing where to go for Papanicolaou tests” had a 
Mann Whitney U test mean rank of 29.13 for women who had not obtained a 
Papanicolaou test for over three years (infrequent group) compared to women who had 
obtained Papanicolaou tests at least every three years (frequent group) with Mann 
Whitney U test mean rank o f 19.88 (z = -2.58, p  = .01). Women who were infrequent in 
obtaining Papanicolaou tests more consistently agreed that not knowing where to go 
influenced their decision. Differences in responses between the infrequent group and
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frequent group to the barrier “inconvenient time” was found to be signifrcant with Mann 
Whitney U test mean rank o f 28.98 for women in the infrequent group compared to Mann 
Whitney U test mean rank o f 20.02 for women in the frequent group (z = -2.34, g = .02). 
Differences in responses to the barrier of “not believing Papanicolaou tests were 
important” was also found to be significant with Mann Whimey U test mean rank o f 
28.65 for women in the infrequent group compared to Mann Whitney U test mean rank of 
20.35 for women in the frequent group (z = -2.20, g = .03).
Benefits. Two benefits were found to have significant differences in responses 
between the frequent group and infrequent group when tested with the Mann Whimey U 
test: (a) Papanicolaou tests help to find cervical cancer early and (b) regular Papanicolaou 
tests could prevent radical surgery if cervical cancer occurs. The benefit regarding 
Papanicolaou tests “help to find cervical cancer” early was found to have significant 
differences with a Mann Whimey U test mean rank o f 20.56 for women in the infrequent 
group compared to a Mann Whimey U test mean rank of 28.44 for women in the frequent 
group (z = -2.19, g = .03). The benefit regarding regular Papanicolaou tests could 
“prevent radical surgery if cervical cancer occurs” also had significant differences with a 
Mann Whimey U test mean rank of 20.73 for women in the infrequent group compared to 
Mann Whimey U test mean rank of 28.27 for women in the frequent group (z = -2.18, 
g = .03). Women who obtained Papanicolaou tests frequently were more consistent in 
agreeing that these two benefits were important to their decisions.
It was found in this smdy that women under age 65 more often agreed that certain 
barriers influenced their decisions to have Papanicolaou tests than women 65 and older. 
More women under 65 years of age agreed that cost, inconvenient time, and discomfort
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were barriers. In contrast, more women age 65 and older agreed that Papanicolaou testing 
was not important. There was no real difference in agreement regarding embarrassment 
and lack o f insurance or worry. Numbers were too small to test statistical significance of 
difference (see Table 5). More women age 65 and older disagreed that certain cues to 
action and benefits had influenced their decisions to have Papanicolaou tests than women 
under age 65 (see Table 6 and Table 7).
Table 5. Comparison of Women’s Responses bv Age Regarding Barriers
65 and over Under 65
Agreement Agreement
Interview Question (n = 48^________ (n_)_____ %________ (n j %__________ ____
Lack of insurance coverage (6) 12.50% (7)14.60%
Having a Pap test would be
embarrassing (7) 14.60% (6) 12.50%
Costs too much (3) 6.25% (7) 14.60%
Having a Pap test would 
make me worry about
cancer (5) 10.41% (5) 10.41%
Inconvenient time (2) 4.16% (6)12.50%
Having a Pap test would
be painful (3) 6.25% (5)10.41%
Didn’t think testing for 
cervical cancer
was important (5) 10.41% (2) 4.16%
4 1
Table 6. Comparison o f  Women’s Responses bv Ape Regarding Cues to Action
Interview Question 
(n = 48)
65 and Over Under 65 
Disagreement Disagreement 
(n) % (n) %
Someone you know, recently diagnosed 
with cancer, wanted you to take better 
care of your health 19 (39.60%) 11 (22.91%)
A family member reminded you 20 (41.66%) 15 (31.25%)
Clinic/physician/nurse recommended 
you have a Pap test 9(18.75%) 6 (12.50%)
Table 7. Comnarison o f  Women’s Resnonses bv Age Regarding Benefits
Interview Question 
(n = 48)
65 and Over 
Disagreement 
(n) %
Under 65 
Disagreement 
(n) %
Having a Pap test will decrease the 
chances of requiring radical surgery 
if cervical cancer occurs 6(12.50%) 1 (2.08%)
Having a Pap test will decrease the chances 
o f dying from cervical cancer 6 (12.50%) 1 (2.08%)
Having a Pap test will help 
find cancer early 6(12.50%) 1 (2.08%)
Having a Pap test will help find 
abnormal cells before they 
actually become cervical cancer 3 (6.25%) 0 (0.00%)
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Other Findings of Interest
Subjects were asked to respond in their own words if anything else had strongly 
influenced their decisions to have Papanicolaou tests. This question yielded interesting 
answers. Eight subjects had been told by their health care provider that they didn’t need 
Papanicolaou tests. Seven o f  these women had received a hysterectomy and one had 
received an oophorectomy. Not feeling anything was wrong influenced two subjects not 
to have Papanicolaou tests. They said they knew they would feel it if  anything was wrong 
so they didn’t need Papanicolaou tests. A desire not to know if they had cancer 
influenced two subjects not to have Papanicolaou tests. They stated they didn’t want to 
know if  anything was wrong. Another subject stated she was afraid because she had 
received a biopsy in the vaginal area many years ago that had frightened her from having 
future Papanicolaou tests. One subject stated her health care provider had retired and she 
just hadn’t found another one. Another subject said procrastination prevented her from 
having Papanicolaou tests more frequently, and another stated she simply needed to make 
time for Papanicolaou tests. Five subjects stated they just didn’t think they needed 
Papanicolaou tests.
Three subjects stated they have frequent Papanicolaou tests because they want to 
stay healthy. Another subject stated because she was older she believed she needed to be 
more diligent in obtaining frequent Papanicolaou tests. Although two subjects obtained 
frequent Papanicolaou tests because a family member had contracted cancer and they 
wanted to stay well, another subject stated she did not have Papanicolaou tests because 
two o f her family members had contracted cancer and she was afraid. In addition, one 
older subject obtained Papanicolaou tests more frequently because she was elderly, while
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another stated she didn't need Papanicolaou tests because she was elderly and had to die 
from something.
Summary
Most participants in this study agreed that four benefits had influenced their 
decisions regarding obtaining Papanicolaou tests including: (a) Pap tests help find 
abnormal cells before they become cervical cancer, (b) Pap tests help find cervical cancer 
early, (c) Having Pap tests could decrease chances of dying from cervical cancer, and (d) 
having Pap tests could prevent radical surgery if cervical cancer occurs. When the Mann 
Whitney U test was applied to benefits, two benefits were found to have significant 
differences in responses between the frequent and infrequent groups. These included the 
beliefs that (a) Papanicolaou tests help to find cervical cancer early, and (b) having 
Papanicolaou tests could prevent radical surgery if cervical cancer occurs. More women 
in the infrequent group disagreed that those benefits had influenced their decisions to 
obtain Papanicolaou tests. The majority of the sample agreed that clinic/physician/nurse 
recommendation had influenced their decisions regarding obtaining Papanicolaou tests. 
One-third of the sample agreed that media information had influenced their decisions.
Few study participants agreed that barriers had influenced their decisions. 
Twenty-seven percent o f study participants agreed that embarrassment and lack of 
insurance had influenced their decisions not to obtain Papanicolaou tests, however. When 
the Mann Whitney U test was applied, statistically significant differences between the 
frequent and infrequent groups were found in relation to five barriers. These included (a) 
not knowing where to go for Papanicolaou tests, (b) inconvenient times, (c) Papanicolaou 
tests are not important, (d) Papanicolaou tests will help find cancer earlier, and (e)
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Papanicolaou tests will decrease chances of radical surgery if  cervical cancer occurs. The 
infrequent group responded more often that those barriers had influenced their decisions 
regarding obtaining Papanicolaou tests.
It was found in this study that women 65-years-old and older had obtained 
infrequent Papanicolaou tests compared to women under age 65. It was also found that 
women 65 and older more frequently identified certain barriers as being significant in 
influencing their decisions to obtain Papanicolaou tests. In addition, more women 65 and 
older disagreed that certain cues to action and benefits to having Papanicolaou tests had 
influenced their decisions.
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CHAPTER 5
DISCUSSION AND IMPLICATIONS 
Discussion o f Findings and Conclusions
There are many women age 50 and older who do not have frequent Papanicolaou 
tests. In fact, many women age 65 and older have not had a Papanicolaou test since their 
last child was bom. Women’s risk for cervical cancer increases with age. Most cervical 
cancers grow slowly. Precancerous cells and localized cancerous cells can be identified 
via Papanicolaou tests before the cancer becomes invasive. This is due to an 
asymptomatic phase, which is usually prolonged. Therefore, annual Papanicolaou testing 
decreases women’s risk o f cervical cancer. There is a lack of consensus among health 
care providers regarding recommended frequency o f Papanicolaou tests. Most agree that 
every 1 to 3 years is sufficient as long as a woman is not considered high risk. Different 
definitions of high risk exist and women may not admit to high-risk behavior due to the 
sensitive nature o f this information.
In this study, to determine what influences women age 50 and older to obtain 
Papanicolaou tests, it was found that few study participants agreed barriers had 
influenced their decisions. However, when the Mann Whitney U test was applied, it was 
found that women who had obtained Papanicolaou tests every 4 or more years (infrequent 
group) agreed that certain barriers had influenced their decisions more than women who 
had obtained Papanicolaou tests at least every 3 years (frequent group). When the Mann
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Whitney U test was applied to cues to action, no differences were found between the 
frequent group and the infrequent group. However, when the Mann Whitney U test was 
applied to benefits, the frequent group was in agreement that certain benefits had 
influenced their decisions more than those women in the infrequent group. Age was also 
found to be a factor in women’s decisions with women age 65 and older being less likely 
to obtain frequent Papanicolaou tests.
Barriers. Barriers in this study are beliefs or perceptions women age 50 and older 
have regarding the negative aspects o f obtaining a Papanicolaou test or impediments to 
obtaining a test. Barriers were not found to influence decisions about obtaining tests. The 
vast majority o f the sample (68% - 96%) disagreed that any barrier had influenced their 
decisions about obtaining a Papanicolaou test. Over one-fourth o f study participants 
(27%), however, agreed that embarrassment had influenced their decisions regarding 
obtaining Papanicolaou tests (M = 2.48, SD = 1.29). Although not statistically significant, 
this barrier is o f clinical importance.
Embarrassment has been found to be a significant barrier in other studies 
(Arevian et al., 1997; Hoeman & Ohl, 1996; Suarez et al., 1993; White, 1995). In this 
study, there was not a significant difference in mean ranking o f responses according to 
the Mann Whitney U test between women in the infrequent group and women in the 
frequent group regarding embarrassment. Embarrassment was also found to be more or 
less a barrier for a small group of women in this study regardless o f their age. Some 
women obtained Papanicolaou tests frequently regardless o f embarrassment, while others 
did not. The implications for health care providers are to find ways to lessen 
embarrassment for women obtaining Papanicolaou tests. A female health care provider
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performing the pelvic examination may be part of the answer. More health teaching to 
increase awareness regarding women’s reproductive, peri-menopausal, and 
postmenopausal health issues may also help to decrease embarrassment.
When the Mann Whimey U test was applied to other barriers it was found that 
significantly more women in the infrequent group identified certain barriers as 
influencing their decisions to obtain Papanicolaou tests than women in the fiequent group 
including: (a) they didn’t know where to go for Papanicolaou tests, (b) that Papanicolaou 
tests were offered at inconvenient times, and (c) that Papanicolaou tests were not 
important (see Table 8 in previous chapter). Significantly, more women in the infrequent 
group agreed that they did not know where to go for Papanicolaou tests. There needs to 
be more public information about how to obtain cervical screening so more women know 
where to obtain Papanicolaou tests. In addition, health care providers should encourage 
women to obtain Papanicolaou tests. This service should be provided in the clinical 
setting where women obtain other health services. Mandelblatt et al. (1993) and 
Weintraub et al. (1987) found in their studies that older women will obtain Papanicolaou 
tests if the test is offered in the primary care setting where the women receive other 
health services.
It was also found in this study that women in the infrequent group responded 
more often that Papanicolaou tests are offered at inconvenient times. Cervical cancer 
screenings need to be offered at times other than traditional 9 a m. to 5 p.m. office hours. 
Those women who work or lack transportation during traditional hours could then access 
care during alternative hours.
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Table 8. Mann Whitnev U Comparison o f Perceived Agreement with Barriers
Barrier Grouo tn = 48')
Mean
Rank
z p 
value value
Didn’t know where Infrequent 29.13 -2.58 .01
to go for Pap test Frequent 19.88
Time inconvenient Infrequent 28.98 -2.34 .02
Frequent 20.02
Perceived as not Infrequent 28.65 -2.20 .03
important Frequent 20.35
Believing the Papanicolaou test was not important was also found to be a 
significant barrier in other studies (Suarez et al., 1993; Sutton et al., 1994; White, 1995). 
According to Suarez et al. (1993), a significant barrier was feeling that the examinations 
were unnecessary. In White’s study (1995) it was found that many older women believed 
they didn’t need a Papanicolaou test. Sutton et al. (1994) found that many older people 
are not aware they should have cancer screening. There is a need for education to make 
women aware that anyone can contract cervical cancer and that the risk for cervical 
cancer increases with age. There is also a need for education regarding the fact that 
cervical cancer can be prevented by obtaining frequent Papanicolaou tests and by treating 
precancerous cells.
Cues to action. Cues to action in this study are stimuli that prompt women age 50 
and older to obtain Papanicolaou tests. Cues to action can be symptoms of disease or 
prompting through media or through interpersonal relationships. In this study, only one 
cue was viewed as important by the majority (60%) o f the sample. This was health care
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provider recommendation. A third of the sample were influenced by media information; 
while only 27% agreed that someone they knew who was recently diagnosed with cancer, 
and wanted them to take better care o f their health, was influential. Twenty-one percent 
responded that reminding by a family member had influenced their decision to obtain a 
Papanicolaou test.
Burnett et al. (1995) found that a positive patient-provider relationship and respect 
for clients influenced women to have cancer screenings including Papanicolaou tests. 
According to Allen et al. (1993), when a health care provider takes more time and 
addresses a woman’s concerns, she is more likely to have frequent Papanicolaou tests and 
other preventive health services. Brown (1996) found that an important reason women do 
not obtain Papanicolaou tests is that their physician does not tell them they need it. 
Hoeman et al. (1996) found that the most important cue to action in their study was when 
women accessed care for obstetrical services, they received a Papanicolaou test. Women 
age 50 and over do not need obstetrical services and many do not obtain frequent 
Papanicolaou tests. Health care provider recommendation is an important factor in 
influencing women’s decisions to obtain frequent Papanicolaou tests.
Media information was less influential in this study. Suarez et al. (1993) found in 
their study that newspaper information, radio information, and cable television 
information served as stimuli for increased numbers o f persons being screened for breast 
and cervical cancer. Hoeman et al. (1996) found mass media to be influential in women’s 
decisions to participate in preventive health behaviors. The media is a powerful tool that 
can be used to influence women’s decisions to obtain frequent Papanicolaou tests. There 
is less hesitation now to mention women’s special health needs on television, in
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magazines, and in newspapers. There are advertisements for feminine products and for 
medications to improve sexual function. Older men and women are used as characters in 
these productions and articles. A similar approach could be used to promote cervical 
cancer screenings. This could help to decrease embarrassment while increasing 
knowledge. Educational programs through the media should not just be directed towards 
the women who need to be screened. Others who may influence women to obtain cervical 
cancer screening need to be educated so they can encourage women to obtain 
Papanicolaou tests. This could be a family member, friend, or an acquaintance.
Therefore, education needs to be widespread and directed toward a diversified audience.
Twenty-seven percent of the women interviewed in this study agreed that when 
someone they knew had cancer and wanted them to take better care o f their health, it 
influenced their decisions to have Papanicolaou tests. Nearly 21% o f women interviewed 
in this study agreed that when a family member reminded them to obtain Papanicolaou 
tests it influenced their decisions. A study by Hoeman et al. (1996) found that husbands 
were significant cues to action for women to obtain Papanicolaou tests. Burnett et al.
( 1995) found that the influence o f significant others toward having Papanicolaou tests 
was positively related to women obtaining Papanicolaou tests annually. Although this cue 
did not differentiate between women on the basis of frequency o f obtaining cancer 
testing, it may be important to educate husbands and other family members to prompt 
older women to obtain frequent Papanicolaou tests.
Benefits. Benefits are defined as the beliefs or perceptions women have regarding 
how having Papanicolaou tests will positively affect their health. In this study benefits 
were perceived as significant in influencing women age 50 and over to obtain
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Papanicolaou tests. The vast majority o f  subjects agreed that all four benefits evaluated 
were important to their decisions about cervical cancer testing. Only the opportunity for 
precancerous diagnosis and decreasing the chance of dying from cervical cancer 
differentiated between the frequent and infrequent groups, however. Women who 
obtained infrequent testing were more consistent in disagreeing that these factors were 
important in their decisions. The results are shown in Table 9.
Table 9. Mann Whitnev U Comparison o f Perceived Agreement with Benefits
Benefit Groun Rank Value Value
Having a Pap test 
will help find cervical 
cancer early
Frequent
Infrequent
28.44
20.56 -2.19 .03
Having a Pap test 
will decrease the 
chances of requiring 
radical surgery if 
cervical cancer occurs
Frequent
Infrequent
28.27
20.73 -2.18 .03
These differences demonstrate that women in the less frequent group may have 
been less aware that precancerous cells could be detected by the Papanicolaou test. They 
may have been less aware that cervical cancer could be detected early and even prevented 
by finding precancerous cells as a result o f having frequent Papanicolaou tests. There 
needs to be more education regarding the benefits o f having frequent Papanicolaou tests 
including early detection, detection o f precancerous cells, and decreased need for radical 
surgery when cervical cancer is detected early. This education needs to be directed 
toward all women and especially those women who do not have frequent Papanicolaou
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tests. In addition, family members, fnends, and the general public need to be educated so 
they can prompt women age 50 and older to obtain frequent Papanicolaou tests.
Systems problems. Health care providers must come to some consensus regarding 
recommended frequency of Papanicolaou tests with regard to women age 50 and older. 
Morrison (1997) found that different medical organizations recommend different 
screening intervals for Papanicolaou tests. Most agree that high-risk women should be 
screened annually with the exception o f the American College o f Physicians which 
recommends screening high risk women every 2 years. All medical organizations also 
agree that women who are not considered high risk should be screened at least every 3 
years. Women age 65 and older and women who have received a hysterectomy are not 
included. There is a lack o f consensus regarding whether women age 65 and older and 
women who have received a hysterectomy should obtain Papanicolaou tests at all.
There are two definitions o f high risk according to Morrison (1997). The first 
definition o f high risk includes: (a) women who have had multiple sexual partners, (b) 
women who have male sex partners who have had multiple partners, (c) women who 
became sexually active at an early age, (d) women with a current or past history o f  herpes 
simplex virus or human papilloma virus or condylomas, (e) women with immuno­
suppression including human immunodeficiency virus infection, (f) women with sexually 
transmitted infections, (g) women who smoke, (h) women who abuse substances, (i) 
women with a history of cervical dysplasia or gynecologic malignancy, and 0) women in 
a lower socioeconomic group. The second definition of high risk, used by some 
physicians to determine frequency of Papanicolaou testing, includes: (a) women who 
have had multiple sex partners, (b) women who began having sexual intercourse at a
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young age, (c) women who have had a sexually transmitted infection, (d) women who 
take birth control pills, and (e) Black, Hispanic and Native American women. These two 
definitions do not leave out many women in today’s society. According to Morrison
(1997), “recommendations from medical organizations differ regarding which risk factors 
are most important, probably because good outcome data are not available. ^Tien to stop 
Pap screening in older women is also controversial” (p. 1284).
The Cervical Cancer Control Plan for Michigan (CCCPM), which was written by 
the Cervical Cancer Advisory Committee at Michigan Department of Community Health
(1998), states that the guidelines for Papanicolaou testing are not consistent and they are 
not uniform among different physician groups for women of all ages, most especially for 
women over 65 years of age and women who have had a hysterectomy. Unscreened 
populations, according to the National Institutes o f Health Consensus Development Panel 
(NIH Consensus Development Panel, 1996), include older women, uninsured, ethnic 
minorities and poor women. “Although older women are screened less frequently, they 
have the same number o f recent physician visits as younger women, which indicates the 
need to educate older women and their health care providers about the importance o f Pap 
smear screening” (p. viii). The CCCPM (1998) recommends annual Papanicolaou testing 
because increased frequency of Papanicolaou testing will decrease false negative tests. 
Edelman and Mandle (1994) recommend annual Papanicolaou testing. Brown (1996) also 
recommends annual Papanicolaou testing.
Health care providers need to come to some consensus regarding the necessity 
and recommended frequency o f Papanicolaou testing for women. This includes 
Papanicolaou testing for women age 50 and older and women who have received a
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hysterectomy. According to Weintraub et al. (1987, p. 870) “elderly women are routinely 
omitted from screening, as it Is generally believed that they usually refuse this testing.” 
Weintraub et al. (1987) and Mandelblatt et al. (1993) found in their studies that women 
age 65 and over would accept Papanicolaou testing especially if  it was offered by the 
health care provider who provided other health services. In addition, Weintraub et al. 
found significant abnormalities while screening women age 65 and older. Many women 
in Weintraub et al.’s study who had received hysterectomies did not know the reason for 
the hysterectomy at the time of the study. A very small number still had their cervix. 
None of the women in Weintraub et al.’s study who had received hysterectomies due to 
cancer had obtained any follow-up gynecological examinations or screenings after the 
hysterectomy. This demonstrates a need for frequent Papanicolaou tests for older women 
including those who have received a hysterectomy.
Weintraub et al. (1987) recommends Papanicolaou testing after hysterectomy, 
while Morrison (1997) does not. Many health care providers encourage Papanicolaou 
testing regardless o f whether a woman has had a hysterectomy. There needs to be a 
standard that all health care providers follow. This standard should not be solely based on 
cost savings o f the Papanicolaou test. Costs when the Papanicolaou test is not done and 
cervical cancer occurs needs to be considered as well. A clear definition o f high risk 
needs to be developed. A method for determining if women are high risk needs to be 
developed, as many women will not share this kind of sensitive information with anyone. 
Papanicolaou testing must be offered by the primary health care provider at a convenient 
time and location. Health care providers must encourage women age 50 and older to 
obtain frequent Papanicolaou tests including women 65 years and older and those women
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who have received a hysterectomy.
Age related influences. There were 14 women age 65 years and older in the less 
frequent group compared to 11 women age 65 and older in the more frequent group.
There were 10 women under age 65 in the infrequent group, and 13 women under age 65 
in the more frequent group. Four women age 65 and older had received a hysterectomy 
and were told they did not need to have Papanicolaou tests. Five women age 65 and older 
were told they should have Papanicolaou tests but were in the infrequent group. Women 
age 65 and older were less likely to obtain Papanicolaou tests in this study.
All women age 65 and older responded that health care recommendation had not 
influenced their decisions to have Papanicolaou tests. More women age 65 and older 
identified one barrier as having influenced their decisions to obtain Papanicolaou tests. 
This was that they didn’t think testing for cervical cancer was important. This may 
indicate that the older women in this study lack knowledge regarding the importance o f 
frequent Papanicolaou testing. This barrier has been documented in previous studies 
(Suarez et al., 1993; Sutton et al., 1994; White, 1995). Papanicolaou tests were 
introduced in the 1940s. At this time many older women were accessing health care for 
gynecological services during an era when Papanicolaou tests were not routinely 
recommended for older women. Several older women may have only had pelvic 
examinations during their childbearing years. Mandelblatt and Hammond (1984) found 
that older women in their study did not obtain Papanicolaou tests as often as younger 
women. They postulated this could be because the current older population of women 
were ending their child producing years when the Papanicolaou test first became 
routinely recommended. These women may not have sought gynecological care after
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their reproductive years were finished.
The importance o f positive relationships between a health care provider and 
patient in regard to women obtaining frequent Papanicolaou tests has been documented 
by Burnett et al. (1993). If a woman is treated badly by her health care provider she will 
not come back for preventive care. Many women age 65 and older do not drive. They 
must rely on others for transportation. There is a need for health care providers to be 
aware that older women may need assistance in obtaining transportation for Papanicolaou 
testing and other preventive care.
In this study, more women age 65 and older disagreed that three cues to action 
had influenced their decisions to obtain Papanicolaou tests. It has been documented that 
older women have fewer Papanicolaou tests. They often rely entirely on their health care 
provider for recommendations for preventive health care. Because there are inconsistent 
guidelines regarding frequency or need for Papanicolaou tests for women age 65 and 
over, there may have been no health care provider recommendation or conflicting health 
care provider recommendations. Older family members and friends of women age 65 and 
older would likely have similar beliefs regarding the need for frequent Papanicolaou tests 
since they come from the same era. There is a need for generalized education regarding 
the benefits for older women having frequent Papanicolaou tests.
More women age 65 and older were in disagreement with the four benefits to 
obtaining Papanicolaou tests than women under age 65. More women in this study age 65 
and older did not understand the benefits of obtaining frequent Papanicolaou tests. There 
is a need for more education regarding the need for frequent Papanicolaou testing for 
women age 50 and older, health care providers, and for the general public.
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Women between the ages of 50 and 64 more often identified certain barriers as 
infiuencing their decisions to obtain Papanicolaou tests than women age 65 and older (see 
Table 6). These barriers included: (a) costs too much, (b) inconvenient time, (c) having a 
Pap test would be painful, and (d) lack of insurance coverage. Women under 65 years of 
age have different needs and concerns than those women over 65 years old. They may 
still be caring for children or involved in a career which prevents them from accessing 
care during regular 9 a.m. to 5 p.m. office hours. Their time may be more limited than 
women age 65 and older. Most women age 65 and older have Medicare health insurance. 
Women under 64 do not have Medicare health insurance. Therefore, cost and lack of 
insurance are more important influences on their decisions to obtain Papanicolaou tests. 
Other Findings o f  Interest
Study participants were asked if anything else had strongly influenced their 
decisions regarding obtaining Papanicolaou tests. Eight women (16%) in this study were 
told by their health care provider that they didn’t need a Papanicolaou test because they 
had received a hysterectomy or oopherectomy. Two women in this study had obtained 
frequent Papanicolaou tests because a family member had contracted cancer and they 
didn’t want to contract cancer. One woman in this study did not have Papanicolaou tests 
because she had family members who had contracted cancer and she was scared. She 
didn’t want to know if  she had cancer.
Over six percent o f the sample stated they knew they would feel it if anything was 
wrong and so didn’t need to have Papanicolaou tests. Five women (10.4%) in this study 
stated they just didn’t think they needed a Papanicolaou test. Two women (4.16%) stated 
they didn’t want to know if  anything was wrong. Another stated she was afinid to obtain
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a Papanicolaou test because she had experienced a problem previously. One older subject 
had more frequent Papanicolaou tests because she was elderly. Another older subject 
stated she didn’t need Papanicolaou tests because she was older and had to die from 
something.
It is apparent that what may influence some women to have Papanicolaou tests 
after reaching 50 years o f  age may influence others not to have Papanicolaou tests. It is 
also apparent that there is a need for more education about cervical cancer and the 
importance o f frequent Papanicolaou tests for women age 50 and older as well as 
assessment of beliefs.
Health Belief Model
This study to determine what influences women age 50 and over to obtain 
Papanicolaou tests found that benefits and cues to action were more important than 
barriers. This contrasted with the majority of studies cited in this research in which 
barriers were found to be significant in preventing women from having Papanicolaou 
tests (Arevian et al., 1997; Suarez et al., 1993; Sutton et al., 1994; White, 1995). In other 
studies related to women’s health. Champion (1993) found both benefits and barriers to 
be predictive for utilization o f breast cancer screening services with barriers being most 
significant. Rutledge (1987) found perceived benefits and barriers to be significant to 
BSE. Kim et al. (1991) found barriers and health motivation to be most important in 
explaining calcium intake and exercise behaviors in the prevention o f osteoporosis. Stein 
et al. (1992) found perceived susceptibility to be more significant along with physician 
recommendation in their study regarding use o f mammograms. Mandelblatt et al. (1993) 
found that perceived benefits and barriers were not significant in their study regarding
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cervical cancer screening.
The HBM has been used effectively to study health behaviors for 40 years. 
Perceived benefits and perceived barriers have been found to have the greatest 
relationship with health promoting behaviors (Becker et al., 1977; Champion, 1993; 
Hiject, 1984; Kim et al., 1991; Kirscht, 1974; Leventhal et al., 1983; Rosenstock, 1974; 
Rutledge, 1987; & Stein et al., 1992) with barriers and benefits having more or less 
influence in particular studies. The HBM was helpful in organizing the framework for 
this study by examining barriers, cues to action, and benefits that could influence 
women's decisions to obtain Papanicolaou tests.
Implications for Clinical Practice
There is a need for more education for women age 50 and older, significant 
persons in their lives including friends, family, and others regarding the need for 
Papanicolaou testing for all women. There is a need for more education for health care 
providers regarding the need for frequent Papanicolaou tests for older women. Health 
care providers need to have one standard recommended frequency for Papanicolaou 
testing for women age 50 and older that is followed by all. Women age 50 years and 
older should have access to Papanicolaou testing in their primary care provider's office 
where they receive other health services. Annual Papanicolaou testing should be offered 
and encouraged by the health care provider during each visit. Health care providers need 
to educate women age 50 and older regarding the need for Papanicolaou tests. They 
should have written information regarding what the test is, how it is performed, and the 
benefits to obtaining frequent Papanicolaou tests. Women age 50 and older need to know 
that they are at risk for cervical cancer. They need to be educated to understand that they
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can have cervical cancer and not be aware of it. They need to know that when a woman 
has cervical cancer there may not be any symptoms until the cancer is advanced. Family 
members, friends, and the general public need to be educated about the importance o f 
Papanicolaou tests for older women.
Health care providers need to consistently recommend annual Papanicolaou tests. 
Annual Papanicolaou tests should be recommended for women age 50 and older 
including women over age 65. The health care provider should ask women age 50 and 
older why they do not obtain Papanicolaou tests. An effort must be made to assess the 
woman’s beliefs and to understand her motivation so that she can be helped to understand 
the importance o f cervical screening. Health care providers should try to find ways to 
make the testing possible. Insurance companies need to pay for Papanicolaou testing 
annually. Women with fewer resources often cannot afford to obtain annual Papanicolaou 
testing. There needs to be a payment method that can be utilized so that women without 
insurance can afford to obtain frequent Papanicolaou tests. Preventing cervical cancer is 
more cost effective than treating the disease. Papanicolaou tests need to be offered before 
9 a.m., after 5 p.m., and on Saturdays so women who have other commitments during 
regular office hours can access care. Women without transportation may need assistance 
from the health care provider to find community resources that can transport them to the 
clinic for Papanicolaou testing. Health care providers need to spend enough time with 
women age 50 and older to make them feel comfortable. These women need to feel like 
their questions and concerns are welcome and significant. They also need to know that 
their health care provider cares enough about them as a patient, and that there will be an 
effort to problem solve with them. Because women respond in different ways to the fear
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of cancer, health care providers must assess if fear is preventing frequent Papanicolaou 
testing. If  fear is preventing frequent Papanicolaou testing, the health care provider must 
find ways to decrease the fear and encourage the test.
Embarrassment is a barrier to women obtaining Papanicolaou tests. The provision 
of Papanicolaou tests by women could minimize embarrassment. Nurse practitioners, 
nurse midwives, and physician assistants could be employed to provide this service. More 
female physicians would also help meet this need. Increased information in the media 
about women’s health issues may help to desensitize women regarding the 
embarrassment associated with Papanicolaou testing and the pelvic exam. Television 
specials and magazine articles emphasizing the need for frequent Papanicolaou tests 
would be very helpful. The use o f focus groups in communities might increase 
awareness, decrease embarrassment, and provide education. Peer educators could be 
trained to educate other women about the need for frequent Papanicolaou tests.
Limitations of the Studv
The sample is a limitation o f the study which was rural, middle class, and 
predominately Caucasian. The results of this study cannot be generalized to any other 
population. Small sample size is another limitation. Some women who were asked to 
participate in the study refused because they didn’t believe in Papanicolaou tests. Two 
potential subjects were eliminated from the study after 24 interviews were completed 
with women who obtain frequent Papanicolaou tests. The interview tool is a limitation 
because it was assembled from other tools for this study and had not been tested in the 
present format. The questions on the interview tool did not include the words “and this 
influenced my decisions.” This would have been helpful to the subjects in keeping the
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focus on the need to give information based on what had influenced their decisions not 
based on their education or knowledge. Questions regarding barriers were grouped 
together. Questions regarding cues to action were grouped together, and questions 
regarding benefits were grouped together. It may have been beneficial to intermingle 
questions. Selection o f subjects included referral from the physician at the clinic when he 
became aware a subject had not had a Papanicolaou test in 4 or more years. Thus, sample 
selection was not random. Subject education level and income level was not included in 
the interview. This could be a limitation when comparing the data from this study to data 
from other studies. There was no question in the interview regarding preference for a 
woman performing the Papanicolaou test rather than a man. There was no question 
regarding whether the healthcare provider had recommended frequent Papanicolaou tests. 
Some women offered the information that a recommendation had or had not been made, 
but this question was not asked specifically. There was no question regarding whether a 
woman had received a hysterectomy. In addition, Papanicolaou test frequency was self- 
reported and could have been inaccurate.
Suggestions for Further Research
More research needs to be done using a much larger sample so that multivariate 
analysis could be conducted to better identify those factors that differentiated between the 
frequent and infrequent groups. Further research should be done in different areas of the 
country including all ethnic and socioeconomic groups to determine what influences 
older women’s decisions regarding obtaining Papanicolaou tests. In addition, 
recommended frequency o f Papanicolaou testing for women age 50 and older needs 
further study. More research must be done to document the need for frequent
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Papanicolaou testing for women after 65 years o f age and for women who have received 
a hysterectomy. There needs to be further studies to determine if  recommendation should 
be made for more frequent or less frequent Papanicolaou testing based on risk factors 
because many women will not divulge this type o f sensitive information. These studies 
must look at morbidity, mortality, and the costs incurred in this age group when cervical 
cancer is not found early compared to the cost o f annual Papanicolaou tests. Cost of 
annual Papanicolaou tests should not be the single deciding factor.
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Appendix A
I give consent for interviews to be done on women age fifty and over at Memphis Medical 
Center. I understand that the information obtained regarding women’s decisions to have, or not 
to have, regular Pap smears will be anonymous and confidential. There will be no cost to the 
women. Participation will be on a strictly voluntary basis. Study results will be available to all
participants.
ideon, M.D.Laj Date
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Appendix B
# LAPEER COUNTY HEALTH DEPARTMENT1575 SUNCREST DRIVE •  LAPEER, MICHIGAN 48446
810-667-0391 #  FAX 810-667-9399
March 1, 1999
Mrs. Dorothy Hicks-Burchwell 
2094 Kooran 
Lapeer, Ml 48446
Bh i /
Dear Mrs. Hicl^p«Burchweii:
Thank you for your recen t request for permission to  com piete 
ciient interview s during the  upcoming Heaithorama even t to  be 
held on March 20 ,1999  sponsored by Lapeer County Health 
Department, am ong others and held a t  Lapeer County Vocational 
Technical School.
It is our understanding th a t the  purpose of th e  ciient interviews 
is for com pletion of research  tow ards requirem ents for a  m asters 
degree and will not be used for financial gain.
The D epartm ent h as  reviewed th e  Informed consen t form and 
questionnaire. Provided th a t you secu re  signed informed 
consen t forms from each  ciient you will be interviewing during 
th e  event, and utilize the  questionnaire, th e  Health Department, 
to  the  ex ten t w e  a re  legally authorized, ex tends perm ission to 
carry out c lien t interviews.
Sincerely,
John  D. Niederhauser, MPH 
Director/Health Officer
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Appendix C
LAMB-STEELE MEMORIAL 
(313)724-6030 • (313) «7-0940
395 E. THIRD STREET 
IMLAY CITY, Ml 48444
IVWCHK3ANS OLDEST COUOTHOUSE
LAPEER c o u n t y  DEPARTMENT OF SENIOR ACTIVITIES
February 19, 1999
Dorothy Hicks-Burchwell 
2094 Keeran Dr.
Lapeer, MI 48446
Dear Dorothy,
Pursuant to our telephone conversation regarding the siuvey you wish to conduct with 
some o f our clients. I did review the draft copy o f the survey that you had sent and also 
spoke to several o f  our clients to see if they would be interested in participating in the 
survey. I have to date seven (7) clients who are interested and give permission for you to 
interview them.
For your convenience you may do the interviews at our Lapeer Center. Just let me know 
in advance the date and time. I f  you should have any questions/concerns please feel free 
to contact me at (810)724-6030 or (810)667-0940.
Sincerely,
an Coffey, Director
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Appendix D
Date
Dear
My name is Dorothy Hicks-Burchwell. I am a Certified Nurse Practitioner 
working on a Master o f Science Degree in Nursing. I am doing a study to find out 
the things that make it difficult for women over 50 to get Pap tests. The answers 
you can give will help us to better meet the health needs of women. Your 
participation in this study is strictly voluntary, but I hope you will sit down and take 
a few minutes to answer some questions I will be asking you.
The information you give me will help us understand why some women do 
not have regular Pap tests. Your responses will be anonymous. All information will 
be confidential.
Thank you in advance for your assistance. You will help make a difference in 
the delivery of women’s health care by helping us understand the problem better.
If you have any questions about the study, you may call me at (810) 664-5048 
or (810) 392-2192.
Sincerely,
Dorothy Hicks-Burchwell, R.N.C., W.H.N.P.
If you have any questions about your rights as a subject in a study, you may 
contact Dr. Paul Huizenga, Chair of the Human Research Review Committee at 
Grand Valley State University (616) 895-2472.
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Appendix E
INFORMED CONSENT FORM
I understand that this study is of the factors which influence a woman’s decisions whether to have, 
or not to have, regular Pap tests. The women in this study will be 50 years o f age or older. The 
knowledge gained from this study is expected to help nurses and physicians to provide Pap tests 
in a manner which will be responsive to the needs o f women 50 years o f age and over.
I also understand that;
1. Participation in this study will involve a 15-minute interview regarding what influences 
my decisions regarding having Pap tests.
2. That I have been selected for participation because I am a woman age 50 or over.
3. It is not anticipated that this study will lead to physical or emotional risk to myself and 
it may be helpful to talk to someone about why I do or do not have regular Pap tests.
4. The information I provide will be kept strictly confidential and the data will be coded 
so that identification of individual participants will not be possible.
5. A summary o f  the results will be made available to me upon my request.
I acknowledge that:
“I have been given an opportunity to ask questions regarding this research study, and that 
these questions have been answered to my satisfaction.”
“In giving my consent, I understand that my participation in this study is voluntary and 
that I may withdraw at any time using the postcard provided by Dorothy Hicks- 
Burchwell, without affecting the care I receive fi’om my physician or the staff at Memphis 
Medical Center.”
“I hereby authorize the investigator to release information obtained in this study to 
scientific literature. I understand that I will not be identified by name.”
“I have been given the phone numbers o f the researcher and the chairperson of the Grand 
Valley State University Human Research Review Committee. I may contact them at any 
time if I have questions.”
I acknowledge that 1 have read and understand the above information, and that I agree to 
participate in this study.
Witness Participant’s Signature
Date Date
.1 am interested in receiving a summary o f the study results.
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Appendix F
Code #______________
What Affects Women’s Decisions to Have Regular Papanicolaou Tests?
(Interviewer Read the following instruction SLOWLY)
Regular Papanicolaou (Pap) tests as defined in this study are Pap tests that are done 
annually.
I am going to ask you some questions about your past frequency o f having Pap tests and 
why you chose to have or not to have Pap tests There are no right or wrong answers Everyone 
has different experiences which will influence how she feels. After I read each statement, tell me 
if you STRONGLY DISAGREE. DISAGREE, are NEUTRAL. AGREE. OR STRONGLY 
AGREE with the statement. I will give you a card with these five choices written on it. When I 
read a statement to you, tell me which o f the five choices is your choice.
It is important that you answer the way you belfpve and not the way you think you should 
believe or how you think I may want you to answer. I need your answers to best explain how you
feel.
PLEASE ANSWER THE FOLLOWING QUESTIONS INDICATING HOW 
IMPORTANT EACH FACTOR LISTED BELOW WAS IN YOUR DECISIONS TO HAVE 
OR NOT TO HAVE A PAP TEST
u
3 <
1 1  i 1 1
SD D N A SA 1
SD D N A SA 2
SD D N A SA 3
SD D N A SA 4
SD D N A SA 5
SD D N A SA 6
s. Did not have insurance coverage.
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SD D N A SA 7.
SD D N A SA 8.
SD D N A SA 9.
SD D N A SA 10
SD D N A SA 11
SD D N A SA 12.
SD D N A SA 13.
SD D N A SA 14.
SD D N A SA 15.
SD D N A SA 16.
SD D N A SA 17.
SD D N A SA 18.
SD D N A SA 19.
SD D N A SA 20.
SD D N A SA 21.
SD D N A SA 22.
SD D N A SA 23.
 Inconvenient location.
 Inconvenient time.
test. (Please explain).
other media information about the need for Pap tests.
 Clinic/physician/nurse recommended you have a Pap test.
you to take better care of your health.
cervical cancer.
Having a Pap test will decrease tl 
surgery if cervical cancer occurs.
Having a Pap test will help find al 
actually become cervical cancer.
 Other (Please specify)_________
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324. Please tell me your race.
(1) African American (3) Asian (5) Hispanic
(2) American Indian (4)Caucasian (6) Other
25. Have you ever had a Pap test?
(1) Yes (2) No
26. How often have you had a Pap test in the past ten years?
( 1 ) Never (2) Every year (3) Every two to three years (4) Every four or more years
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Appendix G
.G RA N D  
IVALLEY 
'STATE 
UNIVERSITY
1 CAMPUS DRIVE •  ALLENDALE MICHIGAN 49401-9403 •  616Æ95-6611
November 22, 1999
Ms. Dorothy Hicks-Burchwell 
2094 Keeran Dr.
Lapeer, MI. 48446
Dear Ms. Hicks-Burchwell,
Thank you for your interest in the Osteoporosis Health Belief Scale (OHBS). You have my 
permission to use some the wording for the directions for administering your instruments. 
You may also use and modify some of the questions from the instrument so that they will be 
relevant for decision making regarding Papnicolaou Tests.
I wish you much success with your study.
Sincerely, '1
. A- JLljJ
Phyllis Gendler, PhD, RN, CS, FNP, GNP 
Professor
Kirkhof School o f Nursing 
Grand Valley State University 
Phone: 616-895-3516 
E-mail: gendlerp@gvsu.edu
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Appendix H
I n d i a n a  U n i v e r s i t y
School of Nursing
November 24, 1997
Dorothy Hicks-Burchwell 
2094 Keeran Dr.
Lapeer, MI 48446
ûNiER FOR Nursing Researœ
llllM iddkD rive 
Indianapolis, Indiana 
46202-5107
317-274-7627 
Fax; 317-278-2021
Dear Ms. Hicks-Burchwell,
I have enclosed a copy of my Health Belief Model and other requested materials. 
You have my permission to use these materials. I only require that you send me a 
copy of the completed results.
Sincerely,
Victoria L. Champion, RN, DNS, FAAN 
Professor and Associate Dean for Research 
Mary Margaret Walther Named Professor
wpdocs\vc\instr.Ilr
Located on Ae carr^ m of 
Indiana University 
Purdue University 
IndiarutyoUs
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Appendix I
L o m b a r d i  G v n g e r  C e n t e r  
Research •  Education •  Treatment
D i v i s io n  o f  C .v v c e r  P r e \ f_n t i o n  v n d  C O N T R O L
G e o r g e t o w n  U n iv e r s it v  M e d ic a l  C e n t e r
2233 W is c o n s in  A v e n u e  N W  
S u i t e  400 
W a s h i n g t o n , DC 20007 
T e l e p h o n e ; (202) 687-0800 
F a x : (202) 687-0651
Offices in 
Washington, DC 
Rockviiie, MD 
Arlington, VA
Novembers, 1997
Dorothy Hicks-Burchwell, RNC, MA 
2094 Keeran Drive 
Lapeer, MI 48446
Dear Mrs. Hicks-Burchwell:
I would like to thank for your interest in my instrument entitled, "Barriers to Breast and Cervical 
Screening.” If you decide to use any or all of the instrument please forward yoiu* results of the 
analysis of validity and reliability to me.
1 would be interested in your findings, so please feel free to send me a copy of your thesis or 
manuscript.
Sincerely,
L
Caroline Burnett, Sc.D., R.N.
A Comprehensive Cancer Center Designated by the National Cancer Institute
Appendix J
G r a n d \ ^ l e y
SlATE UMIVERSITY
I CAMPUS DRIVE • ALLENDALE, MICHIGAN 49401-9403 • 616/895-6611
March 11, 1999
Dorothy Hicks-Burchwell 
2094 Keeran Drive 
Lapeer, MI 48446
Dear Dorothy:
Your proposed project entitled "A Study to Determine Why Some Women Over Age 
Fifty Decide not to have Regular Papanicolaou Tests" has been reviewed. It has 
been approved as a study which is exempt from the regulations by section 46.101 of 
the Federal Register 46( 16):8336, January 26, 1981.
Sincerely,
Paul Huizenga, Chair
Human Research Review Committee
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